Operations of the Business Sample Clauses

Operations of the Business. The operation of the Business by Buyer UK and the other Purchasing Entities after the Transfer Date, except to the extent that a Purchasing Entity is entitled to indemnification from the Indemnifying Selling Entities pursuant to Section 11.1;

Operations of the Business. From the date of execution of the Letter of Intent through the date of execution of the Management Agreement, Seller has operated the Business only in the usual, regular and ordinary course and manner consistent with past practices, and has not entered into agreements or transactions with any Person, including any Affiliate (except for Buyer), or incurred obligations which would or could reasonably be expected to have a material, adverse impact on the operations, financial status or condition, or prospects of the Business. From the date of execution of the Management Agreement, Seller has operated, and will continue through the Closing Date to operate, the Business in accordance with and subject to the Management Agreement and in accordance with and subject to Section 5.1 hereof.

Operations of the Business. Nothing contained in this Section 2.13 shall restrict Purchaser’s right to manage and control its businesses, assets, operations or activities in any respect, including that of its Subsidiaries, including the hiring or termination of employees, the incurrence of expenses and requiring compliance with Purchaser’s and its Affiliates’ internal controls, corporate governance policies and procedures, legal and regulatory compliance standards and consumer data guidelines and privacy rules and regulations. Seller Parent acknowledges that (i) upon the closing of the transactions contemplated by the Agreement and except as expressly provided to the contrary in this Agreement, Purchaser has the right to operate and use the Purchased Assets, the Assumed Liabilities, the Shares and its other businesses in any way that Purchaser deems appropriate in its sole discretion, (ii) neither Purchaser nor its Subsidiaries have any obligation to operate their businesses, assets, operations or activities (including the Purchased Assets, the Assumed Liabilities and the Shares) in order to achieve the Earnout Cap, maximize the Adjusted EBITDA during the Earnout Period, or to increase the Earnout Percentage, (iii) the Earnout Target is speculative and is subject to numerous factors outside the control of Purchaser and its Subsidiaries, (iv) there is no assurance that Seller Parent will receive any earnout amount pursuant to this Section 2.13 and Purchaser has not promised nor projected any earnout amount will be achieved, and (v) the Parties solely intend the express provisions of this Agreement to govern their contractual relationship with respect to any earnout amount. Notwithstanding the foregoing, Purchaser and its Subsidiaries shall not act in bad faith, or otherwise intentionally take actions, in each case, with the purpose of reducing Adjusted EBITDA, with the purpose of delaying, impeding, avoiding or preventing payment of any earnout amount to Seller Parent pursuant to this Agreement, or enter into, including by way of amendment or modification, extension or renewal of, any document, agreement or instrument the purpose of which is to restrict or prohibit the payment of any earnout amount due under this Agreement.

Operations of the Business. (a) Between December 31, 2008 and the date hereof, other than those actions taken in connection with the sale process conducted by Seller with respect to the Branch Business, which are listed on Section 2.18 of the Seller Disclosure Letter, Seller has conducted the Branch Business only in the ordinary course consistent with past practice. Without limiting the generality of the foregoing, since December 31, 2008, Seller has not, in respect of the Branch Offices: (i) Changed its interest rate or fee pricing policies with respect to Deposits or Loans other than in the ordinary course of business consistent with past practice; (ii) Increased the salary, remuneration, or compensation or benefits of Employees, other than normal increases in accordance with Seller’s customary annual review and performance based remuneration policies as in existence on the date hereof, or paid or committed to pay any bonus to any such Employee; (iii) Terminated any Employee, except in the ordinary course of business consistent with past practice; (iv) Hired or promoted any Employee except in the ordinary course of business consistent with past practice or transferred or reassigned any Employee other than to or from another Branch Office, in the ordinary course of business consistent with past practice; (v) Amended, terminated, waived, assigned or modified the terms of any Loan or Deposit except in the ordinary course of business consistent with past practice; (vi) Amended, waived or modified Seller’s standard loan and deposit underwriting, credit servicing and operating policies and procedures; (vii) Sold, assigned or transferred any Branch Deposits to any other Person; (viii) Released, compromised or waived any material claim or right for the benefit of Seller that constitutes an Asset except in the ordinary course of business consistent with past practice; (ix) Sold, transferred, conveyed, or otherwise disposed of any Asset; (x) Placed or suffered an Encumbrance (other than a Permitted Encumbrance) upon any Asset; or (xi) Closed, sold, consolidated, or relocated any Branch Office.

Operations of the Business. Since January 1, 2016, Silvercrest has carried on its business in the usual, regular and ordinary course, consistent with past practices, in all material respects. Silvercrest has not, directly or indirectly, given or agreed to give (or authorized any manager, officer, employee, representative or agent to give or agree to give), and, to its knowledge, no manager, officer, employee, representative or agent of Silvercrest has given, any gift or similar benefit to any Client, Governmental Authority or other Person who is or may be in a position to help or hinder Silvercrest’s business which (a)(i) violated, or was for the purposes of concealing a violation of, Applicable Law and (ii) subjected or could reasonably be expected to subject Silvercrest to any damage, penalty or other Liability in any civil, criminal, administrative or regulatory proceeding or other Litigation, or (b) if not given in the past, or if not continued in the future, had or could reasonably be expected to materially and adversely affect the business of Silvercrest.

Operations of the Business. 63 6.5 Notices. . . . . . . . . . . . . . . . . . . . . . . . . . . . 65 6.6 Disclaimer as to Physical Condition. . . . . . . . . . . . . . 65 6.7

Operations of the Business. The Former Company Stockholders acknowledge that the Parent is entitled to manage its business and the business of its Subsidiaries, including the Company, as it may determine in its sole discretion, provided, that (x) the Parent shall not nor shall the Parent cause or permit the Parent or any of its Subsidiaries to take any action or to make any operational changes for the purpose of intentionally reducing or eliminating any Earn-Out payments pursuant to this Section 3.3(i) (whether during the Earn-Out Period or thereafter) otherwise payable to the Former Company Stockholders and (y) until the date on which the aggregate amount of payments made pursuant to this Section 3.3(i) equal the Maximum Earn-Out Payment, the Parent shall not own, directly or indirectly, any Person whose business does not consist of a

Operations of the Business. During the Earn-Out Periods, the Parties acknowledge that Buyer and its Affiliates intend to use commercially reasonable efforts to operate the Business in accordance with the terms of the operating plan described in Exhibit 1.4(e), as such plan may be amended by the mutual agreement of Buyer and Management (the “Operating Plan”). During the Earn-Out Period, management of the Business, which shall be A▇▇▇▇▇▇ and/or M▇▇▇▇▇ as long as each is employed by Buyer or its Affiliates (together or individually, as the case may be, “Management”), shall be responsible for managing the Business in accordance with the terms and conditions of the Employment Agreements. The Operating Plan sets forth a list of items or actions that, if taken by Buyer or its Affiliates without the consent of Management, will give Management the right to request an adjustment to EBITDA for the Earn-Out Periods adversely impacted by such item pursuant to Section 1.4(f). Subject to the rights of Sellers and Management under this Agreement and Management’s rights under the Employment Agreements, Buyer will have the right to operate the Business in accordance with its own commercially reasonable discretion, and Buyer is not under any obligation to provide any specific level of investment or financial assistance to the Business. Sellers acknowledge that the payment of any Earn-Out Payment is speculative and subject to, among other things, the future performance of the Business and the San Bernardino Facility and general economic conditions, which cannot be predicted with accuracy. Accordingly, Buyer makes no representations, warranties, covenants or guaranties as to future performance or the likelihood of any payments pursuant to this Section 1.4. Buyer shall, at all times during each Earn-Out Period, maintain separate books of account for each of the Business and the San Bernardino Facility for purposes of calculating payments to Seller's hereunder.

Operations of the Business. Except as to obligations related to the continued development of Treanda set forth below in this Section 2.2(e), the Parties understand and agree that Parent shall have complete discretion with respect to all decisions related to the research, development, manufacture, marketing, pricing and distribution of the compounds, product candidates and business of the Surviving Corporation and Parent. Following the Effective Time, Parent agrees to use, or to cause the Surviving Corporation to use, Commercially Reasonable Efforts to seek FDA Approval for the treatment of NHL or CLL. Parent agrees to devote, or cause Surviving Corporation to devote, Commercially Reasonable Efforts to conduct at least one Phase III clinical trial of Treanda in NHL in a timely manner following the Effective Time.